ELP Gold Leader - Horizon Discovery

Picture of company lab techs at workstation  Lab tech of company at sequencer

Horizon Discovery logo  Icon representing greenhouse gas reduction Icon representing materials management Icon representing community support

Horizon Discovery
Member since 2012

Our Mission
Horizon was founded by Dr. Chris Torrance and Professor Alberto Bardelli in 2007 when they came across an impressive gene editing platform, rAAV, which enabled the ability to tailor-make cell lines with virtually any genomic modification.
Since then the company has grown rapidly, with offices in the UK, Europe and the U.S. Horizon now offers an extensive range of catalogue products and related research services to support a greater understanding of the function of genes across all species and the genetic drivers of human disease and the development of personalised molecular, cell and gene therapies. These have been adopted by over 10,000 academic, drug discovery, drug manufacturing and clinical diagnostics customers around the globe, as well as in the Company’s own R&D pipeline.
Our Contribution to Life Sciences
Horizon’s offerings are built around our proprietary translational genomics platform, a high-precision and flexible suite of gene editing tools able to alter almost any endogenous gene sequence of human or mammalian cell-lines. Based from that launch pad, Horizon now offers over 23,000 catalog products, almost all of which are based on the application of gene editing to generate cell lines that accurately model the disease-causing mutations found in genetically based diseases.